Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)

Aim. To study the prescribed drug therapy, as well as adherence to it in patients with acute coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods. The study included 327 patients who were in hospital treatment with ACS: 199 patients (60.9%) with...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
Format: Article
Language:English
Published: Столичная издательская компания 2019-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1798
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227672471732224
author L. A. Khaisheva
S. E. Glova
V. A. Suroedov
A. S. Samakaev
S. V. Shlyk
author_facet L. A. Khaisheva
S. E. Glova
V. A. Suroedov
A. S. Samakaev
S. V. Shlyk
author_sort L. A. Khaisheva
collection DOAJ
description Aim. To study the prescribed drug therapy, as well as adherence to it in patients with acute coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods. The study included 327 patients who were in hospital treatment with ACS: 199 patients (60.9%) with unstable angina (UA) and 128 (39.1%) – with acute myocardial infarction (AMI). The prescribed treatment and adherence to therapy were evaluated within 12 months after the coronary event. Therapy prescribed to patients was compared with current clinical guidelines for the treatment of patients with ACS. Results. 67% of patients completed the clinical study Adherence to prescribed medication within 12 months after ACS was maximal for ACE inhibitors/angiotensin receptor blockers (83.6%), dual antiplatelet therapy (79.9%) and β-blockers (78.1%), and minimal for lipid-lowering drugs (statins; 61.6%). A significant decrease in adherence was revealed in 6 and 12 months from the initiation of therapy. Significantly higher level of adherence to DAT was found in patients with AMI compared with patients with UA (p<0.05). When analyzing the frequency of occurrence of endpoints, it was found that patients who did not adhere to treatment significantly more often had hospitalizations due to UA (15.1% vs 7.4%; p<0.05), AMI (16.9% vs 8.1%; p<0.05), death from cardiovascular causes (13% vs 10.4%; p<0.05). Conclusion. Therapy prescribed at the outpatient stage in patients with ACS in the Rostov Region corresponds to the modern clinical recommendations. Six months after hospital discharge adherence to drug therapy in patients is reduced, which requires more careful outpatient monitoring during this period. In patients who are not adherent to treatment, cardiovascular complications are significantly more frequent.
format Article
id doaj-art-a4487542d20b436d8ec0e71d8f04055d
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-a4487542d20b436d8ec0e71d8f04055d2025-08-23T10:00:30ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-01-0114685285710.20996/1819-6446-2018-14-6-852-8571549Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)L. A. Khaisheva0S. E. Glova1V. A. Suroedov2A. S. Samakaev3S. V. Shlyk4Rostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityAim. To study the prescribed drug therapy, as well as adherence to it in patients with acute coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods. The study included 327 patients who were in hospital treatment with ACS: 199 patients (60.9%) with unstable angina (UA) and 128 (39.1%) – with acute myocardial infarction (AMI). The prescribed treatment and adherence to therapy were evaluated within 12 months after the coronary event. Therapy prescribed to patients was compared with current clinical guidelines for the treatment of patients with ACS. Results. 67% of patients completed the clinical study Adherence to prescribed medication within 12 months after ACS was maximal for ACE inhibitors/angiotensin receptor blockers (83.6%), dual antiplatelet therapy (79.9%) and β-blockers (78.1%), and minimal for lipid-lowering drugs (statins; 61.6%). A significant decrease in adherence was revealed in 6 and 12 months from the initiation of therapy. Significantly higher level of adherence to DAT was found in patients with AMI compared with patients with UA (p<0.05). When analyzing the frequency of occurrence of endpoints, it was found that patients who did not adhere to treatment significantly more often had hospitalizations due to UA (15.1% vs 7.4%; p<0.05), AMI (16.9% vs 8.1%; p<0.05), death from cardiovascular causes (13% vs 10.4%; p<0.05). Conclusion. Therapy prescribed at the outpatient stage in patients with ACS in the Rostov Region corresponds to the modern clinical recommendations. Six months after hospital discharge adherence to drug therapy in patients is reduced, which requires more careful outpatient monitoring during this period. In patients who are not adherent to treatment, cardiovascular complications are significantly more frequent.https://www.rpcardio.online/jour/article/view/1798acute coronary syndromesecondary preventionadherence to treatmentreal clinical practice
spellingShingle L. A. Khaisheva
S. E. Glova
V. A. Suroedov
A. S. Samakaev
S. V. Shlyk
Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
Рациональная фармакотерапия в кардиологии
acute coronary syndrome
secondary prevention
adherence to treatment
real clinical practice
title Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
title_full Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
title_fullStr Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
title_full_unstemmed Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
title_short Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
title_sort evaluation of drug therapy and adherence to it in patients after acute coronary syndrome in real clinical practice results of one year observation
topic acute coronary syndrome
secondary prevention
adherence to treatment
real clinical practice
url https://www.rpcardio.online/jour/article/view/1798
work_keys_str_mv AT lakhaisheva evaluationofdrugtherapyandadherencetoitinpatientsafteracutecoronarysyndromeinrealclinicalpracticeresultsofoneyearobservation
AT seglova evaluationofdrugtherapyandadherencetoitinpatientsafteracutecoronarysyndromeinrealclinicalpracticeresultsofoneyearobservation
AT vasuroedov evaluationofdrugtherapyandadherencetoitinpatientsafteracutecoronarysyndromeinrealclinicalpracticeresultsofoneyearobservation
AT assamakaev evaluationofdrugtherapyandadherencetoitinpatientsafteracutecoronarysyndromeinrealclinicalpracticeresultsofoneyearobservation
AT svshlyk evaluationofdrugtherapyandadherencetoitinpatientsafteracutecoronarysyndromeinrealclinicalpracticeresultsofoneyearobservation